162 related articles for article (PubMed ID: 34379172)
1. Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors.
Toyoda J; Sahara K; Tsilimigras DI; Miyake K; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Pawlik TM
World J Surg; 2021 Dec; 45(12):3643-3651. PubMed ID: 34379172
[TBL] [Abstract][Full Text] [Related]
2. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
3. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
4. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
5. Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
Zhang J; Peng CS; Tian YH
Clin Interv Aging; 2019; 14():1419-1432. PubMed ID: 31496669
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
[TBL] [Abstract][Full Text] [Related]
9. Propensity score-matched analysis of clinical outcome after enucleation versus regular pancreatectomy in patients with small non-functional pancreatic neuroendocrine tumors.
Weilin M; Xu H; Yang L; Wenqi C; Huanyu W; Wentao Z; Dayong J; Wenchuan W; Dansong W; Tiantao K; Lei Z; Wenhui L; Xuefeng X
Pancreatology; 2020 Mar; 20(2):169-176. PubMed ID: 31941586
[TBL] [Abstract][Full Text] [Related]
10. Observation Versus Resection for Small, Localized, and Nonfunctional Pancreatic Neuroendocrine Tumors: A Propensity Score Matching Study.
Zhu J; Fu C; Zhang Y; Zhou X; Xiao W; Li Y
Pancreas; 2022 Jan; 51(1):56-62. PubMed ID: 35195596
[TBL] [Abstract][Full Text] [Related]
11. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
[TBL] [Abstract][Full Text] [Related]
12. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
Ge W; Zhou D; Xu S; Wang W; Zheng S
Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
14. A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.
Powers BD; Rothermel LD; Fleming JB; Strosberg JR; Anaya DA
J Gastrointest Surg; 2020 Dec; 24(12):2773-2779. PubMed ID: 31754990
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.
Yang Z; Gao H; Lu J; Niu Z; Zhu H; Zong Y; Song X; Yang F; Zhou X
Jpn J Clin Oncol; 2021 Apr; 51(4):595-603. PubMed ID: 33395471
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
Zhou B; Zhan C; Xiang J; Ding Y; Yan S
BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
[TBL] [Abstract][Full Text] [Related]
18. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
[TBL] [Abstract][Full Text] [Related]
20. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
